WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8101 Infant (under 12 months) mortality rate: 642
GDP / capita (US$): 1'8651 Child (under 5 years) mortality rate: 1002

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 10'880  10'598  10'322  10'050  9'779  6'949  5'001  3'718 
Births 388  382  377  371  366  299  234  176 
Surviving infants 362  357  351  345  340  273  208  154 
Pop. less than 5 years 1'708  1'681  1'656  1'631  1'604  1'245  930  680 
Pop. less than 15 years 4'587  4'501  4'413  4'322  4'228  3'157  2'300  1'671 
Female 15-49 years 2'612  2'533  2'457  2'383  2'311  1'584  1'135  846 

Number of reported cases

(Click for retrospective incidence data for Benin)
Diphtheria
ChartChart
  127 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  55  786  637  288  426  4'244  18'635 
Mumps
ChartChart
 
Pertussis
ChartChart
  215  2'694 
Polio*
ChartChart
  81  155 
Rubella
ChartChart
  40  10  41  20 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  52  247 
Tetanus (total)**
ChartChart
  288  499 
Yellow fever
ChartChart
  10 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Benin)
Vaccine year result method % card seen                                                
BCG 2012  98  CES   89  99*  96  98  97  99*  99*  74 
DTP1 2012  96  CES   89  99*  94  98  94  99*  99* 
DTP3 2012  86  CES   89  98  90  93  85  99*  88  78 
DTP4         
IPV1          61 
HepB_BD         
HepB3 2012  86  CES   89  98  90  93  85  99* 
Hib3 2012  86  CES   89  98  90  93  85  99* 
JapEnc         
MCV1          94  87  87  72  95  85  73 
MCV2         
PCV1          99*  90  98  99*  98 
PCV3          98  90  93  36  69 
Pol3 2011  56  DHS   54  99  90  93  85  99*  88  78 
Rota1         
RotaC         
Rubella1         
TT2plus 2012  85  CES   89  68  69  69  82  77  81  46 
PAB         
VAD1         
YFV 2011  31  DHS   54  94  87  87  72  95 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Benin)
BCG
ChartChart
  88  87  88  88  92  92 
DTP1
ChartChart
  84  84  84  85  89  86 
DTP3
ChartChart
  70  69  76  75  78  74 
HepB3
ChartChart
  70  69  76  75 
HepB_BD
ChartChart
 
Hib3
ChartChart
  70  69  76  75 
MCV1
ChartChart
  63  63  70  70  70  79 
MCV2
ChartChart
 
PAB
ChartChart
  93  93  93  92  87  48 
PCV3
ChartChart
  70  69  76  36 
Pol3
ChartChart
  72  71  78  77  78  74 
RotaC
ChartChart
 
YFV
ChartChart
  64  64  71  71 

Number of districts in the country 77  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 78
From 80 to 89% 13
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9 years; No From May 2016
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes From 2017
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2018  2014-2018  2009-2013  2009-2013    2009-2013  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 77  77  56  77  77  77  77 

System performance

Total Nº districts in country number 77  77  77  77  77  77  77 
Nº districts with DTP3 coverage >=80% number 56  65  73  72  70  70  67 
% of districts with DTP3 coverage >=80% From 0 to 100% 73  84  95  94  91  91  87 
Nº districts with measles (MCV1) coverage >=95% number 29  15  36  19  37  51  26 
% of districts with MCV1 coverage >=95% From 0 to 100% 38  19  47  25  48  66  34 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  NA  Yes  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 33  33  76  17  35  84  52 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.